Equities research analysts at StockNews.com assumed coverage on shares of Bio-Path (NASDAQ:BPTH – Get Free Report) in a report released on Wednesday. The firm set a “sell” rating on the stock.

Hulu's February line-up features thrilling docuseries, new seasons of fan favorites, and exciting premieres for every taste.

All forms of Earth life have specific chemicals in their makeup, such as amino acids and sugars. Scientists have known that ...

When NASA launched a spacecraft to an asteroid, scientists patiently waited for their chance to look at bits of the space ...

Improvements have also been made in plasmid DNA backbones needed to carry CRISPR into target cells for the knock-in process. Novel plasmid DNA backbones are smaller than traditional plasmids, and they ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

In a new study, researchers have unveiled a surprising potential hero in the battle against hair loss: 2-deoxy-D-ribose, a simple sugar molecule that forms the backbone of DNA. Could this natural ...

Sequins, a newly-funded start-up in the next generation sequencing (NGS) ecosystem, announced today the availability of their first commercial products – the Sequins Metagenomics Core Control and ...

Platinum group metals (PGMs), which are hosted overwhelmingly in South Africa, are playing a crucial anti-cancer role as well ...